| View |
|
DRP-4825-05
|
Clarithromycin
|
Rixo
|
250 mg / 5 mL
|
Granules for Suspension
|
Antibacterial (Macrolide)
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
02 February 2024
|
16 October 2028
|
| View |
|
DRP-4839-06
|
Fenofibrate
|
Fenok
|
160 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
24 February 2024
|
16 October 2028
|
| View |
|
DRP-4839-08
|
Fenofibrate
|
Fenogen
|
160 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
26 February 2024
|
16 October 2028
|
| View |
|
DRP-4900-01
|
Naproxen Sodium
|
Penegen
|
550 mg
|
Tablet
|
Non-Steroidal Anti-inflammatory Drug (NSAID)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
02 February 2024
|
07 November 2028
|
| View |
|
DRP-4910-03
|
Vitamin B1 + Vitamin B6 + Vitamin B12
|
Zinerve Forte
|
300 mg/100 mg/100 mcg
|
Capsule
|
Vitamins
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
16 February 2024
|
13 November 2028
|
| View |
|
DRP-4940-18
|
Ceftriaxone (as sodium)
|
Zeftrianav
|
1 g
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Shreechem Pharmaceuticals Pvt., Ltd
|
India
|
CLIDP Conversion
|
06 February 2024
|
20 November 2028
|
| View |
|
DRP-495-09
|
Ciprofloxacin (as hydrochloride)
|
Prozin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Quinolone)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
14 February 2024
|
21 September 2027
|
| View |
|
DRP-495-10
|
Ciprofloxacin
|
Cipromar
|
500mg
|
Film-Coated Tablet
|
Antibacterial (Quinolones)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 February 2024
|
21 September 2027
|
| View |
|
DRP-4987-10
|
Acetylcysteine
|
None
|
200 mg
|
Powder for Oral Suspension
|
Mucolytic
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
03 March 2024
|
05 December 2028
|
| View |
|
DRP-5025-46
|
Omeprazole (as sodium)
|
Technozole
|
40 mg
|
Powder for Injection (IV)
|
Proton Pump (H+K+ATPase) Inhibitor
|
Shreechem Pharmaceuticals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 February 2024
|
27 December 2028
|
| View |
|
DRP-5044-03
|
Fenofibrate
|
Fenosol
|
100 mg
|
Capsule
|
Hypertriglyceridemia
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
08 February 2024
|
07 January 2029
|
| View |
|
DRP-5050-05
|
Clarithromycin
|
Rixo
|
125 mg/ 5 mL
|
Granules for Suspension
|
Antibacterial (Macrolide)
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
02 February 2024
|
09 July 2028
|
| View |
|
DRP-5052-27
|
Cefixime (as Trihydrate)
|
Luxime
|
100 mg / 5 mL
|
Granules for Suspension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
22 February 2024
|
18 August 2027
|
| View |
|
DRP-5052-28
|
Cefixime (as trihydrate)
|
Sufixime
|
100 mg/5 mL
|
Granules for Supension
|
Antibacterial (Third Generation Cephalosporin)
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 February 2024
|
18 August 2027
|
| View |
|
DRP-5129-07
|
Zoledronic Acid (as monohydrate)
|
Zologet
|
4 mg
|
Lyophilized Powder for IV Infusion
|
Bisphosphonates
|
Getwell Pharmaceuticals
|
India
|
CLIDP Conversion
|
26 January 2024
|
20 February 2029
|
| View |
|
DRP-5177-01
|
Esomeprazole (as sodium)
|
Esoziem
|
40 mg
|
Lyophilized Powder for IV Injection/Infusion
|
Proton Pump Inhibitor
|
Sovereign Pharma Pvt. Ltd
|
India
|
CLIDP Conversion
|
26 February 2024
|
20 February 2029
|
| View |
|
DRP-5183-04
|
Paracetamol + Tramadol Hydrochloride
|
Primetram
|
325 mg/37.5 mg
|
Film-Coated Tablet
|
Antipyretic/Opioid Analgesic
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
25 February 2029
|
| View |
DRP-5317-03_PI_01.pdf
|
DRP-5317-03
|
Cinnarizine
|
Vercure
|
75 mg
|
Capsule
|
Anti-Vertigo
|
Lloyd Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 February 2024
|
24 December 2028
|
| View |
|
DRP-5343-05
|
Co-Amoxiclav
|
Duoxiclav
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillins)
|
Giyaan Pharma Private Limited
|
India
|
Renewal
|
07 April 2024
|
17 June 2029
|
| View |
|
DRP-5367-05
|
Cefuroxime (as Axetil)
|
Educef-250
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
01 February 2024
|
30 June 2029
|